drugset / Trial / NCT02718846

Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets

NCT02718846 ↗

Phase 4 Completed 220 enrolled Alvogen Korea
RandomizedParallel-groupOpen-labelTreatment

Summary

A multicenter, randomized, open-label clinical study with a concurrent control group to assess the effectiveness and safety of combined therapy with Isobide solution and Meniace tablets compared to monotherapy with Meniace tablets for patients with Meniere's disease

Timeline

Start
2013-02
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Isosorbide Unknown 90 ml Oral
Background Meniace Unknown 6 mg —

Indications